2 resultados para time history analysis

em Bioline International


Relevância:

80.00% 80.00%

Publicador:

Resumo:

High population growth fragmented rural landholdings leading to low harvests and crop yields per acre per annum creating surplus labour that may resort to migration as a coping mechanism in least developing countries including Ethiopia. The main aim of the study is to assess trends and differentials of out-migration in south central Ethiopia. The Butajira demographic surveillance system database from 1987 to 2008 was used to conduct event history analysis. There were 3.97 out-migrations per 100 person years. Probability of out-migration was higher among males, teenagers, the youth, completed primary and secondary plus education; not in marital union; Christians, urbanites; lived in rented and owed house compared to their respective counterparts. The higher chances of out-migration among these groups may have social and economic significance.

Relevância:

80.00% 80.00%

Publicador:

Resumo:

Respiratory syncytial virus (RSV) infection is the leading cause of hospitalisation for respiratory diseases among children under 5 years old. The aim of this study was to analyse RSV seasonality in the five distinct regions of Brazil using time series analysis (wavelet and Fourier series) of the following indicators: monthly positivity of the immunofluorescence reaction for RSV identified by virologic surveillance system, and rate of hospitalisations per bronchiolitis and pneumonia due to RSV in children under 5 years old (codes CID-10 J12.1, J20.5, J21.0 and J21.9). A total of 12,501 samples with 11.6% positivity for RSV (95% confidence interval 11 - 12.2), varying between 7.1 and 21.4% in the five Brazilian regions, was analysed. A strong trend for annual cycles with a stable stationary pattern in the five regions was identified through wavelet analysis of the indicators. The timing of RSV activity by Fourier analysis was similar between the two indicators analysed and showed regional differences. This study reinforces the importance of adjusting the immunisation period for high risk population with the monoclonal antibody palivizumab taking into account regional differences in seasonality of RSV.